Tejpal Gupta

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Neuro-oncology, Glioma, Medicine +9

Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines

Vincent Grégoire, Mererid Evans, Quynh‐Thu Le et al. · Radiotherapy and Oncology · 2017 · 379 citations · Full text

Medicine, Ncic Ctg, Nasopharyngeal Cancer +10

Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups

Arindam Maitra, Nidhan K. Biswas, Kishore Amin et al. · Nature Communications · 2013 · 356 citations · Full text

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 326 citations

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial

Tejpal Gupta, Jaiprakash Agarwal, Sandeep Jain et al. · Radiotherapy and Oncology · 2012 · 307 citations

Radiation Therapy, Squamous Cell Carcinoma, Three-dimensional Conformal Radiotherapy +9